GlassScriptPhysician profile
Tracy M Hall
NPI 1073768545
$6,129.58
in general payments reported to CMS, 2019-2025
45 companies · $1,367 in 2025
The $1,367 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $518 · 2022: $999 · 2023: $1,317 · 2024: $1,929 · 2025: $1,367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,311 · Education: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,311.13 |
| Education | $302.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $992.91 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $846.13 | 2021-2025 | |
| Astellas Pharma US INC | $834.32 | 2021-2025 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $810.73 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Lilly USA, LLC | $430.49 | 2022-2025 | Mounjaro, Zepbound |
| Amgen INC. | $184.94 | 2021-2025 | Evenity, Prolia, Otezla |
| Abbott Laboratories | $175.85 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Sumitomo Pharma America, INC. | $124.17 | 2024-2025 | Gemtesa |
| Pfizer INC. | $118.01 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $117.09 | 2022-2025 | Farxiga, Airsupra |
| Amarin Pharma, INC. | $116.09 | 2021-2022 | |
| Lundbeck LLC | $110.11 | 2022-2024 | Rexulti |
| Ironwood Pharmaceuticals, INC | $99.08 | 2022 | |
| Azurity Pharmaceuticals, INC. | $93.45 | 2023-2025 | Edarbi, Horizant |
| Mannkind Corporation | $86.39 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.